Found 153 matching trials
CD56+CD3- NK Cells Following Allogeneic Stem Cell Transplantation PHASE1 The investigators propose a nonrandomized, Phase I study to assess the safe...
Show More Location
Hammersmith Hospital
Learn More & Join Trial
SK-NK Injection in Patients With Advanced Solid Tumors Accompanied by Malignant Ascites PHASE1 This study is divided into two phases. Patients with recurrent or metastati...
Show More Location
Multiple Locations
Learn More & Join Trial
Memory-Like Natural Killer Cells With Nivolumab and Relatlimab in Advanced or Metastatic Melanoma After Progression on Checkpoint Inhibitors PHASE1 This is a Phase 1 open-label, study designed to characterize the safety, to...
Show More Location
Washington University School of Medicine
Learn More & Join Trial
Allogeneic Hematopoietic Stem Cell Transplantation for Relapsed or Refractory High-Risk NBL. PHASE2 RATIONALE: - Relapsed or refractory Neuroblastoma (NBL) carries a very poor...
Show More Location
Children's Memorial Hospital
Learn More & Join Trial
A Study of Allogenic Natural Killer Cells in Combination With Trastuzumab and Pertuzumab in Adult Patients With Refractory Metastatic Her2 Positive Breast Cancer. NK-ACT-BC_2020 PHASE1 Breast cancer is the second most common invasive malignancy and the leading...
Show More Learn More & Join Trial
Safety and Efficacy of Intraperitoneal Injection of METR-NK Cells as Neoadjuvant Therapy for Advanced Epithelial Ovarian Cancer PHASE1 The goal of this type of clinical trial study is to evaluate the safety and...
Show More Location
Anhui Cancer Hospital
Learn More & Join Trial
Safety Infusion of NatuRal KillEr celLs or MEmory T Cells as Adoptive Therapy in COVID-19 pnEumonia or Lymphopenia PHASE1 This is a phase I/II clinical trial using adoptive cell therapy with NK cel...
Show More Location
Hospital Universitario La Paz
Learn More & Join Trial
A Safety and Efficacy Trial of Chidamide Combined With NKG2D CAR-NK Cell Therapy for Reducing the HIV Viral Reservoir PHASE1 This study aims to investigate the safety and preliminary efficacy of an in...
Show More Location
the first affiliated hospital of Zhejiang university school of medicine, Hangzhou, Zhejiang 310000
Learn More & Join Trial
Dual-Target CAR-NK Cells for Advanced Breast Cancer (HER2+ and TNBC) PHASE1 This study tests the safety and preliminary anti-tumor activity of an inves...
Show More Location
Peking University Shenzhen Hospital
Learn More & Join Trial
Hepatic Artery Transfusion of NKG2D CAR-NK Cells Followed by Intravenous Infusion of NKG2D CAR-T Cells to Treat Patients With Advanced Solid Tumors With Liver Metastases Who Have Failed Standard Treatments: a Phase I Exploratory Clinical Trial PHASE1 This is a single-center, single-arm, open-label, dose-escalation clinical s...
Show More Location
The First Affiliated Hospital Zhejiang University School of Medicine
Learn More & Join Trial